ACUTE MYELOID LEUKEMIA, IN RELAPSE
Clinical trials for ACUTE MYELOID LEUKEMIA, IN RELAPSE explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOID LEUKEMIA, IN RELAPSE trials appear
Sign up with your email to follow new studies for ACUTE MYELOID LEUKEMIA, IN RELAPSE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New 'Living Drug' trial targets Tough-to-Treat blood cancer
Disease control Not yet recruitingThis early-stage trial is testing a new type of treatment called CCTx-001 for adults with acute myeloid leukemia (AML) that has come back or hasn't responded to other therapies. CCTx-001 is a CAR-T cell therapy, which involves modifying a patient's own immune cells to target and …
Matched conditions: ACUTE MYELOID LEUKEMIA, IN RELAPSE
Phase: PHASE1, PHASE2 • Sponsor: Advesya SAS • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
15-Year watch: tracking patients after experimental cancer cell therapy
Disease control Not yet recruitingThis study will monitor patients for 15 years after they received an experimental CAR-T cell therapy for relapsed or hard-to-treat blood cancers like acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). The main goal is to understand the long-term safety of the treatm…
Matched conditions: ACUTE MYELOID LEUKEMIA, IN RELAPSE
Sponsor: ARCE Therapeutics, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
First patients to receive experimental immune cell treatment for blood cancer
Disease control Not yet recruitingThis is the first-ever study in people to test a new immune cell therapy for acute myeloid leukemia (AML), a serious blood cancer. Researchers will combine a patient's own specially trained immune cells with a vaccine and two standard drugs to see if the approach is safe and can …
Matched conditions: ACUTE MYELOID LEUKEMIA, IN RELAPSE
Phase: PHASE1 • Sponsor: David Avigan • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
Radiation 'Warhead' trial aims to give tough leukemia patients a fighting chance
Disease control Not yet recruitingThis study is testing a new treatment approach for adults with acute myeloid leukemia (AML) that has returned or not responded to standard therapies. It combines a targeted radiation drug with chemotherapy and low-dose whole-body radiation to prepare patients for a stem cell tran…
Matched conditions: ACUTE MYELOID LEUKEMIA, IN RELAPSE
Phase: PHASE2, PHASE3 • Sponsor: Actinium Pharmaceuticals • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC